BI 764532
Boehringer Ingelheim
['lung', 'boehringer']
at doses of 90 g/kg or higher, the overall response rate (orr) for 's bi 764532 was 25% in the overall population (n = 71), and the disease control rate (dcr) was 52%. #asco23 #lungcancer read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.